Differential effect of continuous administration of beta‐adrenoceptor antagonists on antipyrine and phenytoin clearance

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Differential effect of continuous administration of beta‐adrenoceptor antagonists on antipyrine and phenytoin clearance. / Perrild, H.; Kayser, L.; Poulsen, H.E.; Skovsted, L.; Jørgensen, B.; Hansen, J.M.

I: British Journal of Clinical Pharmacology, Bind 28, Nr. 5, 1989, s. 551-554.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Perrild, H, Kayser, L, Poulsen, HE, Skovsted, L, Jørgensen, B & Hansen, JM 1989, 'Differential effect of continuous administration of beta‐adrenoceptor antagonists on antipyrine and phenytoin clearance', British Journal of Clinical Pharmacology, bind 28, nr. 5, s. 551-554. https://doi.org/10.1111/j.1365-2125.1989.tb03541.x

APA

Perrild, H., Kayser, L., Poulsen, H. E., Skovsted, L., Jørgensen, B., & Hansen, J. M. (1989). Differential effect of continuous administration of beta‐adrenoceptor antagonists on antipyrine and phenytoin clearance. British Journal of Clinical Pharmacology, 28(5), 551-554. https://doi.org/10.1111/j.1365-2125.1989.tb03541.x

Vancouver

Perrild H, Kayser L, Poulsen HE, Skovsted L, Jørgensen B, Hansen JM. Differential effect of continuous administration of beta‐adrenoceptor antagonists on antipyrine and phenytoin clearance. British Journal of Clinical Pharmacology. 1989;28(5):551-554. https://doi.org/10.1111/j.1365-2125.1989.tb03541.x

Author

Perrild, H. ; Kayser, L. ; Poulsen, H.E. ; Skovsted, L. ; Jørgensen, B. ; Hansen, J.M. / Differential effect of continuous administration of beta‐adrenoceptor antagonists on antipyrine and phenytoin clearance. I: British Journal of Clinical Pharmacology. 1989 ; Bind 28, Nr. 5. s. 551-554.

Bibtex

@article{01a6e006bbb34d31ad67065057190d80,
title = "Differential effect of continuous administration of beta‐adrenoceptor antagonists on antipyrine and phenytoin clearance",
abstract = "1. Antipyrine (1000 mg orally) clearance was studied 3 days before treatment with either atenolol (50 mg twice daily), metoprolol (100 mg twice daily), propranolol (80 mg twice daily) or placebo, and at day 5 and 18 during treatment. Phenytoin (100 mg intravenously) clearance was measured on days 0, 7 and 21 during treatment. 2. Antipyrine clearance was decreased by about 20% after 5 days of treatment with either propranolol or atenolol and this decrease persisted after 18 days of treatment. Antipyrine clearance did not change during treatment with either metoprolol or placebo. Phenytoin clearance did not change during any of the treatments. 1989 The British Pharmacological Society",
author = "H. Perrild and L. Kayser and H.E. Poulsen and L. Skovsted and B. J{\o}rgensen and J.M. Hansen",
year = "1989",
doi = "10.1111/j.1365-2125.1989.tb03541.x",
language = "English",
volume = "28",
pages = "551--554",
journal = "British Journal of Clinical Pharmacology, Supplement",
issn = "0264-3774",
publisher = "Wiley-Blackwell",
number = "5",

}

RIS

TY - JOUR

T1 - Differential effect of continuous administration of beta‐adrenoceptor antagonists on antipyrine and phenytoin clearance

AU - Perrild, H.

AU - Kayser, L.

AU - Poulsen, H.E.

AU - Skovsted, L.

AU - Jørgensen, B.

AU - Hansen, J.M.

PY - 1989

Y1 - 1989

N2 - 1. Antipyrine (1000 mg orally) clearance was studied 3 days before treatment with either atenolol (50 mg twice daily), metoprolol (100 mg twice daily), propranolol (80 mg twice daily) or placebo, and at day 5 and 18 during treatment. Phenytoin (100 mg intravenously) clearance was measured on days 0, 7 and 21 during treatment. 2. Antipyrine clearance was decreased by about 20% after 5 days of treatment with either propranolol or atenolol and this decrease persisted after 18 days of treatment. Antipyrine clearance did not change during treatment with either metoprolol or placebo. Phenytoin clearance did not change during any of the treatments. 1989 The British Pharmacological Society

AB - 1. Antipyrine (1000 mg orally) clearance was studied 3 days before treatment with either atenolol (50 mg twice daily), metoprolol (100 mg twice daily), propranolol (80 mg twice daily) or placebo, and at day 5 and 18 during treatment. Phenytoin (100 mg intravenously) clearance was measured on days 0, 7 and 21 during treatment. 2. Antipyrine clearance was decreased by about 20% after 5 days of treatment with either propranolol or atenolol and this decrease persisted after 18 days of treatment. Antipyrine clearance did not change during treatment with either metoprolol or placebo. Phenytoin clearance did not change during any of the treatments. 1989 The British Pharmacological Society

U2 - 10.1111/j.1365-2125.1989.tb03541.x

DO - 10.1111/j.1365-2125.1989.tb03541.x

M3 - Journal article

C2 - 2574053

AN - SCOPUS:0024454805

VL - 28

SP - 551

EP - 554

JO - British Journal of Clinical Pharmacology, Supplement

JF - British Journal of Clinical Pharmacology, Supplement

SN - 0264-3774

IS - 5

ER -

ID: 335355756